TrialOpen forum infectious diseases2024

Ceftriaxone Versus Cefazolin Susceptibility as a Surrogate Marker for Cefpodoxime Susceptibility in Enterobacterales.

Kaitlyn V Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.